August 27, 2024 / 12:56 IST
Reported Consolidated quarterly numbers for ANG Lifesciences India are:Net Sales at Rs 18.41 crore in June 2024 down 67.39% from Rs. 56.46 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 3.07 crore in June 2024 down 275.39% from Rs. 1.75 crore in June 2023.
EBITDA stands negative at Rs. 0.43 crore in June 2024 down 106.26% from Rs. 6.87 crore in June 2023.
ANG Lifescience shares closed at 48.69 on August 22, 2024 (BSE) and has given -26.51% returns over the last 6 months and -36.59% over the last 12 months.
| ANG Lifesciences India | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 18.41 | 37.84 | 56.46 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 18.41 | 37.84 | 56.46 | | EXPENDITURE | | Consumption of Raw Materials | 12.24 | 33.06 | 34.14 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.57 | -7.99 | 2.82 | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.26 | 4.15 | 5.76 | | Depreciation | 1.63 | 2.05 | 2.19 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 4.19 | 5.27 | 7.19 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -3.34 | 1.31 | 4.36 | | Other Income | 1.28 | 0.19 | 0.32 | | P/L Before Int., Excpt. Items & Tax | -2.06 | 1.50 | 4.68 | | Interest | 2.08 | 3.84 | 2.31 | | P/L Before Exceptional Items & Tax | -4.14 | -2.34 | 2.36 | | Exceptional Items | -- | -1.74 | -- | | P/L Before Tax | -4.14 | -4.08 | 2.36 | | Tax | -1.07 | -0.43 | 0.61 | | P/L After Tax from Ordinary Activities | -3.07 | -3.65 | 1.75 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -3.07 | -3.65 | 1.75 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -3.07 | -3.65 | 1.75 | | Equity Share Capital | 13.06 | 13.06 | 13.06 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.35 | -2.75 | 1.41 | | Diluted EPS | -2.35 | -2.75 | 1.41 | | EPS After Extra Ordinary | | Basic EPS | -2.35 | -2.75 | 1.41 | | Diluted EPS | -2.35 | -2.75 | 1.41 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
